Development of herbal acupuncture using salmon DNA Presents a new treatment mechanism in the regenerative medical field of homegrown oriental medicine hospitals
Mar 13, 2025
|
The signing ceremony was held at the Jasung Medical Bio Center in Seongnam, Gyeonggi-do, attended by key officials from both organizations, including Lee Jin-ho, head of Jasung Oriental Medicine Hospital, and Oh Bo-kyung, CEO of Genocure.
PDRN is a substance made by extracting human-like genes from the germ cells of salmon or trout. Although it is a nonsteroidal component, it has an excellent effect of promoting cell regeneration of damaged tissues, and the scope of its application is rapidly expanding. Recently, not only skincare but also regenerative medicine has been paying attention.
Accordingly, both institutions expect to improve wounds and pain through the development of PDRN-based acupuncture, reduce inflammation-inducing factors through adenosine A2A receptor reaction, regenerate damaged tissues by promoting growth factor secretion, and improve blood circulation. In particular, PDRN contained in this herbal acupuncture is expected to be processed to a lower molecule than raw materials used in general medical devices and cosmetics, maximizing absorption and treatment effects.
In particular, the two organizations plan to continue to cooperate for the stable supply of PDRN materials and the research and release of medicinal herbs, centering on the Self-Sustaining MediBio Center of Self-Sustaining Oriental Medicine Hospital. The Self-Sustaining Medi-Bio Center is the largest integrated herbal medicine preparation facility in Korea and the second cycle certification of the Ministry of Health and Welfare. It is equipped with automated and standardized high-tech facilities such as water treatment facilities that operate 24 hours a day, as well as systems that thoroughly prevent cross-contamination between raw materials, materials, and waste by operating clean rooms for four grades (Grade A to D).
Lee Jin-ho, Director of Jaseng Oriental Medicine Hospital, said "This cooperation in research and development of PDRN-based herbal medicine is expected to further strengthen the mechanism of integrated medicine treatment and present a new paradigm through the convergence of next-generation biotechnology and oriental medicine."We will continue to strive to provide more effective treatments to patients through continuous research and R&D investment."
"Based on the expertise of self-developed oriental medicine hospitals, we will actively cooperate to ensure that herbal acupuncture using PDRN ingredients becomes a differentiated treatment solution in the domestic and foreign medical markets," said CEO Oh Bo-kyung of Genocure. "We will continue to expand innovative research and development and clinical application." he said.
On the other hand, this PDRN-based herbal medicine development project is also part of the Korea Oriental Medicine Promotion Agency's national project, 'Opening customized corporate support project for the development of oriental medicine products'. This support project supports all stages of research and development, clinical and commercialization of herbal products, and is a system designed to revitalize the industry and research and development of herbal product technology by companies.
|
This article was translated by Naver AI translator.
